医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

MONROVIA, Calif.

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Dr. Maro Kariya of Shinjuku LASIK Clinic in Tokyo, today announced they have entered into a multi-year Strategic Cooperation Agreement to provide STAAR’s EVO Visian ICL™ intraocular lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses through refractive eye treatment.

“I am very proud that my clinic has now joined with STAAR Surgical Company as an official strategic partner to provide STAAR’s ICL as a primary and premium option for patients wanting to experience high quality vision,” stated Dr. Maro Kariya, General Manager of Shinjuku LASIK Clinic. “Our clinic already has several certified ICL surgeons on staff and we look forward to growing and working even more closely with STAAR to achieve our shared goal of providing excellent visual results to patients,” concluded Dr. Kariya.

Caren Mason, President & CEO of STAAR, stated, “Shinjuku LASIK Clinic is a leading provider of refractive surgery in Japan and has demonstrated its commitment to STAAR’s EVO Visian ICL family of lenses by significantly increasing their use of the ICL in recent months. The clinic positions the ICL as a premium option for patients including those with lower-diopter refractive error. Staff members who have had ICL surgery are very happy with their visual freedom results and have positioned the ICL on their website as the primary procedure. This strategic cooperation agreement with Shinjuku LASIK Clinic expands our relationship with growth commitments by the clinic and co-marketing support and certified surgeon and staff training by STAAR.”

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO Visian ICL™ product line. More than 800,000 Visian ICLs have been implanted to date. To learn more about the ICL go to: www.discovericl.com. STAAR has approximately 400 full-time equivalent employees and markets lenses in over 75 countries. Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180814005162/en/